LXRX – lexicon pharmaceuticals, inc. (US:NASDAQ)

News

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA [Yahoo! Finance]
Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
Lexicon Appoints Ivan H. Cheung to Board of Directors [Yahoo! Finance]
Lexicon Appoints Ivan H. Cheung to Board of Directors
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com